Abstract
Clinical Significance of Tumour Markers
Tumour markers are biochemical indicators of the presence of a tumour, which are selectively produced by the neoplastic tissue and released into blood or in other body fluids. They are widely accepted and applied to the management of patients with cancer since the introduction of diagnostic immunopathology. Tumour markers include oncofetal antigens (AFP), glycoproteins (CEA), placental proteins (PLAP), hormones (ACTH and HCG), enzymes (PSA and PAP) and other molecular species. Monoclonal antibody technique is the most commonly used method for identification of specific marker in tissue, urine or blood sample. Assay of various tumour markers can be used for population screening, tumour detection, diagnosis, staging, prognosis or follow up of malignant diseases.
Author(s): Kaushal Kumar, Paras Jain, Anita Sinha, K.K. Singh and H.P. Sharma
Warning: Undefined variable $art_rows in /efsdata/imedpub-com/abstract/abstract-page.php on line 110
Warning: Attempt to read property "select_abs_row" on null in /efsdata/imedpub-com/abstract/abstract-page.php on line 110
Abstract | PDF
Share This Article
Google Scholar citation report
Citations : 3712
American Journal of Phytomedicine and Clinical Therapeutics peer review process verified at publons
Abstracted/Indexed in
- Google Scholar
- Sherpa Romeo
- Genamics JournalSeek
- China National Knowledge Infrastructure (CNKI)
- Open Academic Journals Index (OAJI)
- Directory of Research Journal Indexing (DRJI)
- Publons
- Scientific Journal Impact Factor
- International Committee of Medical Journal Editors (ICMJE)
- Secret Search Engine Labs
- Euro Pub
Open Access Journals
- Aquaculture & Veterinary Science
- Chemistry & Chemical Sciences
- Clinical Sciences
- Engineering
- General Science
- Genetics & Molecular Biology
- Health Care & Nursing
- Immunology & Microbiology
- Materials Science
- Mathematics & Physics
- Medical Sciences
- Neurology & Psychiatry
- Oncology & Cancer Science
- Pharmaceutical Sciences